Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faafbacd692f8f584c47fcca402df63a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 |
filingDate |
2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ca268e9007d14fba55b32f92bf98a0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92225927dbe6f4f2f86327b46a41b50f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a0f780d6b18a86da003bbb977787e87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_797fec26d56d9ef9320c55cfbeecd780 |
publicationDate |
2016-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016340737-A1 |
titleOfInvention |
Epigenetic stem cell commitment-associated signature |
abstract |
Methods for determining the prognosis of a subject having acute myeloid leukemia (AML) as well as methods of treating AML subjects depending on prognosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11137397-B2 |
priorityDate |
2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |